The SafeSeal Hemostasis Patch topical wound dressing is designed to decrease the time it takes to control bleeding from the puncture made into a blood vessel to perform an endovascular procedure.
Medication errors can occur at any point during the medication delivery process from prescribing to dispensing; however ...
February 21, 2008 - Textronics Inc. received FDA clearance to market its textile-based ECG Electrode for use in general ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Siemens Medical Solutions received FDA 510(k) clearance for a 1.5T magnetic resonance imaging (MRI) system that is ...
February 20, 2008 - At HIMSS 2008, Siemens Healthcare will emphasize its image data management solutions for radiology ...
W. L. Gore & Associates (Gore) announced that the FDA granted approval for the use of GORE HELEX Septal Occluder with a modified catheter delivery system indicated for the transcatheter closure of atrial septal defect (ASD), providing a percutaneous ASD closure solution for very young patients.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Toshiba America Medical Systems Inc. recently introduced its Infinix VF-i/SP X-ray system, a universal cardiovascular ...
February 20, 2008 - Philips Medical Systems features at HIMSS 2008 enhancements to its speech recognition solution ...
The ACUSON X300 works to provide compact, portable color Doppler solutions for adult, pediatric, OR, EP and ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
February 2008 - The traditional hospital cleaning methods of wiping down surfaces and mopping floors are now being ...
February 19, 2008 - A regimen of aspirin, clopidogrel and coumadin started at discharge decreased mortality and major adverse cardiac events (MACE) while keeping bleeding to acceptable levels in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) with stent placement, reports a study in the February 26, 2008 issue of the Journal of the American College of Car
February 19, 2008 – A novel, fully bioabsorbable salicylate-based stent offers the potential to reduce adverse events associated with current drug-eluting stents (DES) and could be very beneficial to patients with coronary heart disease, according to a presentation at the Cardiovascular Revascularization Therapies 2008 (CRT) symposium.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
February 19, 2008 – Clinicians implanted the BioMatrix drug-eluting stent system into the first European patients in a live broadcast during the Joint Interventional Meeting (JIM), held in Rome, Italy, from February 13-15. The BioMatrix drug-eluting stent system, by Biosensors International Group Ltd., combines a biodegradable PLA and the company’s proprietary limus drug, Biolimus A9.
February 19, 2008 – The American College of Cardiology (ACC) urges the medical community to oppose cuts to medical ...
February 19, 2008 - Boston Scientific Corp. closed the sale of its Fluid Management and Venous Access businesses to ...